First Tracks Biotherapeutics Announces Participation in Upcoming Investor Conferences
First Tracks Biotherapeutics, a clinical-stage biotech company focused on antibody therapeutics for autoimmune and inflammatory diseases, announced its participation in upcoming investor conferences hosted by Jefferies and Leerink Partners. The company plans to present its clinical pipeline progress and engage in investor meetings in June and July …